Features & Benefits
- Bortezomib is a promising anticancer drug targeting the proteasome.
- Induces cell stress and apoptosis in cancer cells.
- Prevents degradation of pro-apoptotic factors, activating programmed cell death.
- Valuable source of information for researchers and clinicians in oncology and pharmacology.
- Suitable for those working in academia or the pharmaceutical industry.